NCT02203357View on ClinicalTrials.gov

A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

353

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2016

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Hepatitis B vaccine

Hepatitis B vaccine, 60 μg/1ml recombinant hepatitis B vaccine,20 μg/1ml recombinant hepatitis B vaccine, Shenzhen Kangtai Biological Products Co, LTD.

Trial Locations (1)

100191

Peking University, Beijing

All Listed Sponsors
collaborator

Guangxi Center for Disease Control and Prevention

OTHER_GOV

collaborator

Liuzhou City Center for disease control and prevention

UNKNOWN

collaborator

Shenzhen Kangtai Biological Products Co., LTD

INDUSTRY

lead

Peking University

OTHER

NCT02203357 - A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults | Biotech Hunter | Biotech Hunter